State of Wisconsin Investment Board
DNLI icon

State of Wisconsin Investment Board’s Denali Therapeutics DNLI Stock Holding History

State of Wisconsin Investment Board’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.18M Buy
84,652
+2,295
+3% +$47.2K ﹤0.01% 1451
2026
Q1 		$1.58M Buy
82,357
+8,776
+12% +$175K ﹤0.01% 1503
2025
Q4 		$1.21M Sell
73,581
-6,545
-8% -$110K ﹤0.01% 1591
2025
Q3 		$1.16M Buy
80,126
+499
+0.6% +$7.17K ﹤0.01% 1556
2025
Q2 		$1.11M Sell
79,627
-264
-0.3% -$3.72K ﹤0.01% 1531
2025
Q1 		$1.09M Sell
79,891
-13,203
-14% -$253K ﹤0.01% 1463
2024
Q4 		$1.9M Buy
93,094
+11,643
+14% +$298K ﹤0.01% 1305
2024
Q3 		$2.37M Buy
81,451
+4,520
+6% +$112K 0.01% 1236
2024
Q2 		$1.79M Sell
76,931
-3,462
-4% -$66.5K ﹤0.01% 1345
2024
Q1 		$1.65M Sell
80,393
-11,128
-12% -$209K ﹤0.01% 1302
2023
Q4 		$1.96M Sell
91,521
-6,335
-6% -$125K 0.01% 1240
2023
Q3 		$2.02M Sell
97,856
-733
-0.7% -$18.6K 0.01% 1254
2023
Q2 		$2.91M Buy
98,589
+10,763
+12% +$303K 0.01% 1183
2023
Q1 		$2.02M Buy
87,826
+1,260
+1% +$34.7K 0.01% 1302
2022
Q4 		$2.41M Sell
86,566
-990
-1% -$29.5K 0.01% 1268
2022
Q3 		$2.69M Buy
87,556
+417
+0.5% +$13.6K 0.01% 1245
2022
Q2 		$2.56M Sell
87,139
-34,661
-28% -$908K 0.01% 1298
2022
Q1 		$3.92M Hold
121,800
– – 0.01% 1252
2021
Q4 		$5.43M Sell
121,800
-2,200
-2% -$104K 0.01% 1009
2021
Q3 		$6.26M Buy
124,000
+1,300
+1% +$73.3K 0.01% 957
2021
Q2 		$9.63M Buy
122,700
+33,000
+37% +$2.04M 0.02% 782
2021
Q1 		$5.12M Sell
89,700
-3,600
-4% -$241K 0.01% 1012
2020
Q4 		$7.82M Sell
93,300
-7,600
-8% -$459K 0.02% 794
2020
Q3 		$3.62M Buy
100,900
+18,000
+22% +$542K 0.01% 1032
2020
Q2 		$2M Buy
82,900
+2,300
+3% +$54.1K 0.01% 1123
2020
Q1 		$1.41M Buy
80,600
+8,700
+12% +$181K ﹤0.01% 1139
2019
Q4 		$1.25M Hold
71,900
– – ﹤0.01% 1196
2019
Q3 		$1.1M Buy
71,900
+5,700
+9% +$109K ﹤0.01% 1115
2019
Q2 		$1.37M Buy
66,200
+4,500
+7% +$101K ﹤0.01% 1074
2019
Q1 		$1.43M Buy
61,700
+14,100
+30% +$295K ﹤0.01% 1069
2018
Q4 		$983K Buy
47,600
+600
+1% +$10.9K ﹤0.01% 1137
2018
Q3 		$1.02M Buy
+47,000
New +$777K ﹤0.01% 1211

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of Wisconsin Investment Board's DNLI Position: Q2 2026 in Review

State of Wisconsin Investment Board increased its Denali Therapeutics (DNLI) stake by 2.8% in Q2 2026, buying an estimated $47.2K and bringing the position to 84,652 shares worth $2.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1451.

State of Wisconsin Investment Board first reported a position in DNLI in Q3 2018 and has held it in 32 quarters since. The position peaked at $9.63M in Q2 2021. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • State of Wisconsin Investment Board held 84,652 shares of Denali Therapeutics worth $2.18M as of Q2 2026.
  • State of Wisconsin Investment Board bought 2,295 Denali Therapeutics shares in Q2 2026, an estimated $47.2K.
  • Denali Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1451 holding.
  • State of Wisconsin Investment Board first reported a position in Denali Therapeutics in Q3 2018 and has held it in 32 quarters since.
  • State of Wisconsin Investment Board's Denali Therapeutics position peaked at $9.63M in Q2 2021.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.